Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$91,974,244
-$4,528,615 QoQ
Shares Held
1,754,564
+0.3% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $34,817,743,578 across 17 Drug Manufacturers - General names. GSK ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,796,866 | $10,551,225,859 | |
| 2 | JNJ |
Johnson & Johnson
|
28,792,064 | $7,312,320,489 | |
| 3 | ABBV |
AbbVie Inc.
|
20,558,447 | $5,173,327,597 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,275,718 | $3,376,429,761 | |
| 5 | AMGN |
Amgen Inc
|
6,200,994 | $2,245,503,942 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,828,010 | $1,747,030,778 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,918,384 | $1,435,797,281 | |
| 8 | PFE |
Pfizer Inc
|
59,084,573 | $1,422,756,513 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,974,244 | 1,754,564 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $96,502,859 | 1,748,557 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $83,378,443 | 1,700,213 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $98,485,206 | 2,281,863 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $81,228,632 | 2,115,329 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $83,906,344 | 2,165,884 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $69,677,823 | 2,060,255 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $72,482,037 | 1,773,044 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $65,316,135 | 1,696,523 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $73,527,707 | 1,715,132 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $64,245,769 | 1,733,561 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $59,771,825 | 1,648,878 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $52,573,631 | 1,475,130 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $50,584,938 | 1,421,724 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $50,132,303 | 1,426,645 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $43,535,797 | 1,479,300 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $79,937,460 | 1,872,325 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $80,671,815 | 1,888,224 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $90,213,709 | 2,085,708 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $70,348,387 | 1,877,140 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $80,932,862 | 2,072,255 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $90,237,312 | 2,577,859 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $88,785,672 | 2,459,884 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $95,066,211 | 2,575,112 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $102,573,235 | 2,563,893 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $100,081,578 | 2,693,079 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||